Genetic diagnosis of dysplasminogenemia: detection of an Ala601-Thr mutation in 118 out of 125 families and identification of a new Asp676-Asn mutation

Thromb Haemost. 1996 Aug;76(2):135-8.

Abstract

Dysplasminogenemia (plasminogen abnormality) is frequently found in association with thrombosis. Two types of mutation, Ala601-Thr and Val355-Phe, have already been identified; the precise genetic defects of most of these patients, however, remain unknown. In this study, we examined the genetic DNAs of two unrelated cases by single-strand conformational polymorphism and nucleotide sequencing analysis. A new mutation, designated as Asp676-Asn, has been identified in these cases. This mutation leads to the loss of a negatively-charged residue and the creation of a potential carbohydrate attachment site, which may impair the enzymatic properties of plasminogen. As many as 158 individuals with dysplasminogenemia were analyzed by a combination of in vitro amplification and restriction digestion. Among 125 unrelated families, the Ala601-Thr mutation accounted for about 94% of cases. The Val355-Phe mutation was found in four unrelated families, indicating that it is a recurring mutation and is not very rare.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Alanine / chemistry*
  • Asparagine / chemistry*
  • Aspartic Acid / chemistry*
  • Female
  • Genetic Testing / methods*
  • Humans
  • Male
  • Mutation
  • Phenylalanine / chemistry
  • Plasminogen / chemistry
  • Plasminogen / genetics*
  • Plasminogen / physiology
  • Polymerase Chain Reaction / methods
  • Polymorphism, Restriction Fragment Length
  • Polymorphism, Single-Stranded Conformational
  • Sequence Analysis, DNA
  • Structure-Activity Relationship
  • Threonine / chemistry
  • Thrombosis / etiology

Substances

  • Threonine
  • Aspartic Acid
  • Phenylalanine
  • Asparagine
  • Plasminogen
  • Alanine